29
Participants
Start Date
February 23, 2016
Primary Completion Date
August 21, 2019
Study Completion Date
December 31, 2025
Pembrolizumab
Pembrolizumab 200mg every 3 weeks by IV infusion on Day 1 of each 3 week cycle
Paclitaxel
Paclitaxel 80mg/m2 every 3 weeks by IV infusion on Days 1, 8, and 15 of each 3 week cycle
Capecitabine
Capecitabine 2000mg every two weeks by mouth twice each day on days 1-7 of each 2 week cycle.
Cedars-Sinai Medical Center, Los Angeles
Providence Cancer Center, Portland
Merck Sharp & Dohme LLC
INDUSTRY
Providence Health & Services
OTHER